US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist
  • 0.4500
  • -0.0100-2.17%
Close Jan 6 16:00 ET
  • 0.4300
  • -0.0200-4.44%
Post 19:46 ET
2.83MMarket Cap-0.02P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cyclacel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q310.000K / 10.000K--
Aug 14, 20242024/Q24.000K / 15.000K--
May 14, 20242024/Q129.000K / 0.000--
Mar 19, 20242023/Q431.000K / 0.000--
Nov 13, 20232023/Q316.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q310.000K / 10.000K--
Aug 14, 20242024/Q24.000K / 15.000K--
May 14, 20242024/Q129.000K / 0.000--
Mar 19, 20242023/Q431.000K / 0.000--
Nov 13, 20232023/Q316.000K / 0.000--

Unlock Free Earnings Estimates

Cyclacel Pharmaceuticals Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 17:14 ET

  • 8-K: Cyclacel Pharmaceuticals Reports THIRD quarter financial results and provides business update

    Nov 12, 2024 17:04 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 17:10 ET

  • 8-K: Cyclacel Pharmaceuticals Reports SECOND quarter financial results and provides business update

    Aug 14, 2024 16:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+1.43%